Mont-Saint-Guibert, Belgium - Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, today announced that management will participate at both the 13th Annual Wells Fargo Healthcare Conference and the 16th Annual Morgan Stanley Global Healthcare Conference in September.

The Wells Fargo Healthcare Conference will take place in Boston, MA on September 4–6, 2018. The Company presentation is scheduled on Thursday, September 6 at 10:20 a.m. ET.

The Morgan Stanley Global Healthcare Conference will take place in New York, NY on September 12–14, 2018.

Download press release(s)

Press release

88.49 Ko

Celyad Successfully Doses First Colorectal Cancer Patient with CYAD-01 Following Precondit...

Next News

Celyad Successfully Doses First Colorectal Cancer Patient with CYAD-01 Following Precondit...